US$ 25.35
glp-1 receptor agonists alternatives to ozempic You might know them as Ozempic, Wegovy, Mounjaro, and Zepbound. are best known for managing diabetes and promoting weight loss, but researchers are discovering a wide spectrum of effective Ozempic vs Trulicity vs Mounjaro
Description
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
It is important because it provides human biomarker-level support for the idea that GLP-1RA therapy influences redox-related physiology in parallel with its metabolic actions

Diabetes 60: 31033109

doi: 10.1056/NEJMoa1901118

Usage is also high among adults with heart disease, at 26%
